(Q34319076)

1 August 2017

1 reference

title

Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). (English)

1 reference

1 August 2017

0 references

African trypanosomiasis

1 reference

Peter Ge Kennedy

1

1 reference

1 August 2017

21 December 2012

1 reference

1 August 2017

1 reference

1 August 2017

12

1 reference

1 August 2017

2

1 reference

1 August 2017

186-194

1 reference

Human African trypanosomiasis

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Human African trypanosomiasis of the CNS: current issues and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Eliminating human African trypanosomiasis: where do we stand and what comes next?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Human African trypanosomiasis in non-endemic countries (2000-2010)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Human African trypanosomiasis in endemic populations and travellers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

From trypanosomes to the nervous system, from molecules to behavior: a survey, on the occasion of the 90th anniversary of Castellani's discovery of the parasites in sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

The continuing problem of human African trypanosomiasis (sleeping sickness).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Sleeping sickness in Uganda: a thin line between two fatal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Quantifying the level of under-detection of Trypanosoma brucei rhodesiense sleeping sickness cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Prevalence of human African trypanosomiasis in the Democratic Republic of the Congo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Identification of the trypanocidal factor in normal human serum: high density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei brucei

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Diagnostic and neuropathogenesis issues in human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Sleeping sickness in travelers - do they really sleep?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Clinical aspects of 2541 patients with second stage human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Sleep structure: a new diagnostic tool for stage determination in sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Characterization of Trypanosoma brucei s.l. infecting asymptomatic sleeping-sickness patients in Côte d'Ivoire: a new genetic group?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

A CATT negative result after treatment for human African trypanosomiasis is no indication for cure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Options for field diagnosis of human african trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Diagnostic accuracy of molecular amplification tests for human African trypanosomiasis--systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Loop-mediated isothermal amplification for detection of African trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Loop-mediated isothermal amplification (LAMP) method for rapid detection of Trypanosoma brucei rhodesiense

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

African trypanosomiasis: sensitive and rapid detection of the sub-genus Trypanozoon by loop-mediated isothermal amplification (LAMP) of parasite DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Using detergent to enhance detection sensitivity of African trypanosomes in human CSF and blood by loop-mediated isothermal amplification (LAMP).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Molecular diagnostics for sleeping sickness: what is the benefit for the patient?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Diagnosing central nervous system trypanosomiasis: two stage or not to stage?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Identification of stage biomarkers for human African trypanosomiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Polysomnography as a diagnosis and post-treatment follow-up tool in human African trypanosomiasis: a case study in an infant

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Actigraphy in human African trypanosomiasis as a tool for objective clinical evaluation and monitoring: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Human African trypanosomiasis: MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Human African trypanosomiasis: in and out of Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Chemotherapy of human African trypanosomiasis: current and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Potential new drugs for human African trypanosomiasis: some progress at last

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Development of novel drugs for human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Trypanothione is the primary target for arsenical drugs against African trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

An alternative form of melarsoprol in sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

The treatment of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Eflornithine for the treatment of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

A molecular mechanism for eflornithine resistance in African trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970296-X

7 January 2021

10.1016/S1474-4422(12)70296-X

Identifiers

DOI

1 reference

release_5hznj3wdhzelrkeht4vs6vytfi

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5hznj3wdhzelrkeht4vs6vytfi

24 November 2022

mapped directly with Wikidata item

PubMed ID

23260189

1 reference

PubMed ID

23260189